orthocon
-
Biologics
ORTHOCON Announces Signing of Exclusive, Worldwide License Agreement With Bezwada Biomedical
IRVINGTON, N.Y., Aug. 31, 2011 /PRNewswire/ — ORTHOCON, Inc., a privately-held therapeutic device company, today announced the signing of an exclusive, worldwide…
Read More » -
ORTHOCON®, Inc. Receives 510(k) Clearance to Market HEMASORB Apply™
IRVINGTON, N.Y., June 1, 2011 /PRNewswire/ — ORTHOCON®, Inc., a privately-held therapeutic device company, today announced that the Food and Drug Administration…
Read More »